Future Science Group
Browse
cns-2022-0016-Suppl.docx (143.42 kB)

Supplementary Figure 1. An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.

Download (143.42 kB)
figure
posted on 2023-07-18, 13:25 authored by Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Burt Nabors, Michael Salacz, Lynn Taylor, Brian Vaillant, Jaya Gill, Santosh Kesari

Supplementary Figure 1. An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma. 

Funding

This study was funded and supported by EMulate Therapeutics, Inc. (formerly known as Nativis, Inc.). S Kesari was previously an advisor for Emulate Therapeutics, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

History

Usage metrics

    CNS Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC